Arkolith/Insider Trading/ATYR/Form 4

Schimmel Paul

DirectoraTYR PHARMA INC (ATYR) · full profile →Form 4 · filed Oct 9, 2025
Net Buying
Open-Market Buys
$913K
Open-Market Sells
$0
Net Open-Market Flow
$913K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 9, 2025Buy(P)318K$0.94$299K1.4M
Oct 8, 2025Buy(P)682K$0.90$614K1.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-236131) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML